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Active suppression by CD4+CD25+FOXP3+ regulatory T cells (Treg) is essential for the 
maintenance of peripheral tolerance to both self antigens and environmental antigens.  
Absence of these cells in human newborns leads to autoimmune and inflammatory disorders 
as well as allergic disease. Thus, Treg are probably necessary for down-regulating 
autoimmune as well as allergic immune reactions. The aim of this thesis was to examine if 
Treg from birch pollen-allergic patients were able to suppress birch pollen-induced 
proliferation and cytokine production and if their suppressive function was affected 
following specific immunotherapy (SIT) against birch pollen allergy. Moreover, it aimed to 
describe the expression of FOXP3, homing receptors and maturation markers on Treg at 
various time points during the first 3 years of life compared with the expression seen in 
adults. 
 
We found that pollen-allergic patients and non-allergic controls had similar proportions of 
Treg cells in the circulation and that Treg were equally able to potently suppress birch 
pollen-induced proliferation and production of IFN-γ. However, Treg cells isolated during 
birch pollen-season from allergic patients were not able to down-regulate birch-pollen 
induced production of IL-13 and IL-5, in contrast to those from non-allergic controls. 
Likewise, Treg from birch pollen-allergic patients who had undergone SIT for 6 months were 
unable to suppress IL-5 production, while their ability to suppress proliferation and IFN-γ 
production was retained and similar as in untreated allergic controls. Of note, we found that 
IL-10 was produced at higher levels in SIT patients than controls, but only when CD25neg 
cells and Treg were cultured together and not when the CD25neg or Treg cells were cultured 
separately. This indicates that both Treg and CD25neg T cells are important and need to be 
present for an increased production of IL-10 to occur after SIT. 
  
When examining the expression of FOXP3, homing receptors and maturation markers on 
Treg in infants we observed a rapid increase in the proportion of Treg in the circulation 
during the first days of life, indicating conversion to suppressive Treg from CD25high Treg 
precursors. An appropriate localisation of these cells is essential for their ability to suppress 
immune responses and their migration to different tissues is determined by homing 
receptors. We found that that a homing receptor switch from the gut homing receptor 4β7 to 
the extra-intestinal homing receptor CCR4 on Treg started as late as between 18 months and 
3 years of age and was associated with maturation of the Treg. Moreover, the homing 
receptor expression on Treg corresponded to their actual migration properties, since Treg 
from cord blood migrated foremost towards the gut-associated chemokine CCL25.  
In conclusion, our results indicate that Treg from allergic individuals are unable to 
suppress Th2 responses, but not Th1 responses, during birch-pollen season and that SIT 
is unable to restore the ability of Treg to suppress Th2 responses in vitro in spite of an 
increased production of IL-10. Moreover, Treg cells in infants up to 18 months of age 
express 47 and migrate towards gut-homing chemokines, while at 3 years the cells 
have started to mature and to switch into extra-intestinal homing receptors.  
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